The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?
Document Type
Journal Article
Publication Date
2-1-2019
Journal
JAMA Neurology
Volume
76
Issue
2
Inclusive Pages
135-136
DOI
10.1001/jamaneurol.2018.3550
Keywords
Anticonvulsants; Cannabidiol; Drug Approval; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; United States; United States Food and Drug Administration
APA Citation
Yang, Y., & Szaflarski, J. P. (2019). The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?. JAMA Neurology, 76 (2). http://dx.doi.org/10.1001/jamaneurol.2018.3550
Peer Reviewed
1
